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Mutations of mitochondrial DNA are associated with a wide spectrum of disorders, primarily affecting the central nervous
system and muscle function. The specific consequences of mitochondrial DNA mutations for neuronal pathophysiology are not
understood. In order to explore the impact of mitochondrial mutations on neuronal biochemistry and physiology, we have used
fluorescence imaging techniques to examine changes in mitochondrial function in neurons differentiated from mouse embryonic
stem-cell cybrids containing mitochondrial DNA polymorphic variants or mutations. Surprisingly, in neurons carrying a severe
mutation in respiratory complex I (510% residual complex I activity) the mitochondrial membrane potential was significantly
increased, but collapsed in response to oligomycin, suggesting that the mitochondrial membrane potential was maintained by
the F1Fo ATPase operating in ‘reverse’ mode. In cells with a mutation in complex IV causing 40% residual complex IV activity,
the mitochondrial membrane potential was not significantly different from controls. The rate of generation of mitochondrial
reactive oxygen species, measured using hydroethidium and signals from the mitochondrially targeted hydroethidine, was
increased in neurons with both the complex I and complex IV mutations. Glutathione was depleted, suggesting significant
oxidative stress in neurons with a complex I deficiency, but not in those with a complex IV defect. In the neurons with complex I
deficiency but not the complex IV defect, neuronal death was increased and was attenuated by reactive oxygen species scav-
engers. Thus, in neurons with a severe mutation of complex I, the maintenance of a high potential by F1Fo ATPase activity
combined with an impaired respiratory chain causes oxidative stress which promotes cell death.
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Introduction
The most prominent and disabling features in patients with mito-
chondrial disease are often due to neuronal dysfunction and neu-
rodegeneration (Taylor and Turnbull, 2005). The clinical
presentation is extremely variable, ranging from focal deficits
such as optic neuropathy to more global disease such as dementia
and ataxia (McFarland et al., 2007). Only a limited number of
neuropathological studies are available and these show widespread
evidence of neuronal loss and dysfunction (Oldfors et al., 1990;
Sparaco et al., 2003; Betts et al., 2004). Currently, however, we
have limited information on the mechanisms involved in these
patterns of neuronal dysfunction and neurodegeneration.
Understanding these pathological mechanisms is crucial if we are
to develop strategies to treat or prevent the development of
symptoms in patients with mitochondrial disease.
Mitochondrial disease may result from defects of either the
nuclear or mitochondrial genome and there is an increasing rec-
ognition of the importance of these disorders. For example, mito-
chondrial DNA (mtDNA) disorders affect a minimum of 1 in
10 000 adults in the UK (Schaefer et al., 2008). Other reports
suggest that the burden of disease may be much more
common. A study of more than 3000 sequential umbilical-cord
blood samples, taken to investigate the birth prevalence of patho-
genic mtDNA mutations, showed that one mitochondrial tRNA
mutation, the m.3243A4G MTTL1 gene mutation, was present
in the general population at a frequency of 0.14% (Elliott et al.,
2008). The m.1555A4G mitochondrial RNA mutation associated
with aminoglycoside deafness is present in 1 in 200 individuals
from two separate populations (Bitner-Glindzicz et al., 2009;
Vandebona et al., 2009). Furthermore, strikingly similar mitochon-
drial abnormalities and mitochondrial respiratory chain deficient
cells are also present in patients with Alzheimer’s disease
(Bender et al., 2008), Parkinson’s disease and in normal brain
ageing (Bender et al., 2006; Kraytsberg et al., 2006). Therefore
establishing the pathophysiological mechanisms underlying
mtDNA disease may have important implications for other
common forms of neurodegeneration.
There are many different possible approaches to understanding
the mechanisms involved in mitochondrial neurodegeneration, ran-
ging from post-mortem studies in patients (Oldfors et al., 1990) to
the creation of animal models of human disease (Inoue et al., 2000;
Fan et al., 2008; Tyynismaa and Suomalainen, 2009). The latter
approach has many attractions but for mtDNA mutations it is prov-
ing challenging, at least in part because of difficulty in manipulating
the mitochondrial genome. In addition, there is now good evidence
that many pathogenic mtDNA mutations are not transmitted
(Stewart et al., 2008), thus limiting the availability of mice that
can be studied. The approach we have taken is to use cybrid tech-
nology to generate embryonic stem cells that contain pathogenic
mtDNA mutations (Kirby et al., 2009). These embryonic stem cells
can then be differentiated into neurons and glia, and their bio-
chemical and physiological properties investigated. These cell lines
also offer a major advantage in terms of cell imaging, which
enables a comprehensive analysis of the impact of mtDNA muta-
tions specifically on neuronal and glial metabolism and physiology.
The biochemical consequences of mtDNA defects have been
explored on several different cell types, but there have been rel-
atively few studies on neurons (Wong et al., 2002), the main
site of the neuropathology and subsequent clinical features. In
the present study, we have performed an analysis of the mito-
chondrial metabolism of neurons containing mtDNA mutations
that generate either a mild defect of complex IV or a severe
defect of complex I (Kirby et al., 2009). Our studies show very dif-
ferent biochemical phenotypes and responses between the two
cell lines and both are different from control cell lines. These
studies give an important insight into potential mechanisms and
approaches to treatment of neurodegeneration due to mtDNA
mutations.
Materials and methods
Cell lines used in this study were described in detail by Kirby et al.
(2009). All cybrids were derived from ES-1 (CC9.3.1). Control cell lines
were the parental embryonic stem-cell line ES-I and a cybrid (Cy1-I)
with a polymorphic variant (m.9821Adel) in the mitochondrial tRNA
gene for arginine (MTTR). The polymorphic cell line provides an
important control for the process of derivation of the cybrids.
Cybrids with altered electron transport chain function were Cy2-I
and Cy3-I. Cy2-I harbours the m.6589 T4C mutation in one of the
three mtDNA genes encoding complex IV subunits (MTCO1) and
causes a mild complex IV deficit (40% residual complex IV activity).
Cy3-I has two mutations in mtDNA genes encoding different
complex I subunits (m.13887Cins in MTND6 and m.12273G4A in
MTND5) and causes a severe complex I defect (510% residual com-
plex I activity).
Differentiation into neurons
Parental embryonic stem cells and cybrids were differentiated into
neurons using the 4+/4– method (Bain et al., 1995) as described by
Kirby et al. (2009) which also gives full details of markers of differen-
tiation. Cultures were maintained on poly-D-lysine/laminin coated cov-
erslips. Studies were performed on differentiated neurons 7–9 days
post plating.
Imaging cytosolic free calcium
concentration, mitochondrial membrane
potential, reactive oxygen species
generation and glutathione
concentration
Cells were loaded for 30 min at room temperature with 5 mM fura-2
AM (Molecular Probes, Eugene, OR) and 0.005% Pluronic in a
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffered
salt solution composed of (mM): 156 NaCl, 3 KCl, 2MgSO4, 1.25
KH2PO4, 2 CaCl2, 10 glucose and 10 HEPES, pH adjusted to 7.35
with NaOH. For simultaneous measurement of cytosolic free calcium
concentration ([Ca2+]c), and mitochondrial membrane potential (wm),
rhodamine 123 (10mM, Molecular Probes, Eugene, OR) was added
into the cultures during the last 15 min of the fura-2 loading period.
For measurements of wm, cells were loaded with 25 nM tetra-
methylrhodamine methylester for 30 min at room temperature and
the dye was present at the same concentration in all
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solutions throughout the experiment. In these experiments tetra-
methylrhodamine methylester is used in the ‘redistribution mode’
(Duchen et al., 2003) to assess wm, and therefore a reduction in
mitochondrial localized tetramethylrhodamine methylester fluorescence
represents mitochondrial depolarization.
Fluorescence measurements of fura-2 and rhodamine 123 loaded
cells were made using an epifluorescence inverted microscope
equipped with a 20fluorite objective. [Ca2+]c and wm were mon-
itored in single cells using excitation light provided by a Xenon arc
lamp, the beam passing through a monochromator (Cairn research,
Kent, UK) to select wavelengths sequentially at 340, 380 and
490 nm (Cairn Research, Kent, UK) with bandwidths of 10 nm.
Emitted fluorescence light was reflected through a 515 nm long-pass
filter to a frame transfer cooled charge-coupled device camera
(Hamamatsu Orca ER). All imaging data were collected and analysed
using software iQ (Andor, Belfast, UK). The fluorescence data were
acquired at intervals of 5–10 s. The fura-2 data have not been cali-
brated in terms of [Ca2+]c because of the uncertainty arising from the
use of different calibration techniques. Accumulation of rhodamine
123 in polarized mitochondria quenches the fluorescent signal, in
response to depolarization the fluorescence signal is dequenched; an
increase in rhodamine 123 signal therefore signals mitochondrial depo-
larization. Wherever possible, we have normalized the signals between
resting level (set to 0) and a maximal signal generated in response to
the uncoupler carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
(FCCP) (1 mM; set to 100%) (Abramov and Duchen, 2008).
For measurement of mitochondrial reactive oxygen species produc-
tion, cells were pre-incubated with mitochondrially targeted hydroethi-
dine (5 mM, Molecular Probes, Eugene, OR) for 10 min at room
temperature. For measurement of cytosolic reactive oxygen species
production, dihydroethidium (2 mM) was present in the solution
during the experiment. No preincubation (‘loading’) was used for dihy-
droethidium to limit the intracellular accumulation of oxidized
products.
Tetramethylrhodamine methylester measurements were made using
a Zeiss 510 UV-VIS confocal laser scanning microscope equipped with
a META detection system and a 40 oil immersion objective. Illumi-
nation intensity was kept to a minimum to avoid phototoxicity and the
pinhole set to give an optical slice of 2 mm. Tetramethylrhodamine
methylester was excited using the 543 nm laser line and fluorescence
measured using a 560 nm long-pass filter. For hydroethidine and mito-
chondrially targeted hydroethidine measurements a ratio of the oxi-
dized/reduced form was measured: the 543 nm laser line and 560 nm
long-pass filter were used to excite the oxidized form (ethidium) while
excitation 351 nm and measurement at 405–470 nm was used to mea-
sure changes in the reduced form (hydroethidium). All data presented
were obtained from at least five coverslips and two to three different
cell preparations.
Glutathione measurements
To measure glutathione, cells were incubated with 50 mM monochlor-
obimane (MCB) (Molecular Probes, Eugene, OR). As MCB reacts with
glutathione in a reaction catalyzed by gluthatione-s-trasferase, gener-
ating a fluorescent adduct, cells were incubated with the dye in
HEPES-buffered salt solution at room temperature for 40 min, or
until a steady state had been reached before images were acquired
for quantitation (Keelan et al., 2001). The cells were then washed with
HEPES-buffered salt solution and images of the fluorescence of the
MCB-glutathione adduct were acquired using the cooled
charge-coupled device imaging system as described using excitation
at 380 nm and emission at4400 nm.
Cell-death experiments
Cells were stained simultaneously with 20 mM propidium iodide, which
is excluded from viable cells but exhibits a red fluorescence following a
loss of membrane integrity, and 4.5 mM Hoechst 33342 (Molecular
Probes, Eugene, OR), which stains all nuclei and yields blue fluores-
cence to UV illumination, to count the total number of cells. Using
phase contrast optics, a bright field image allowed identification of
neurons, which show a quite distinct morphology compared with the
flatter glial cells and also lie in a different focal plane, above the glial
layer. A total number of 600–800 neurons or glial cells were counted
in 20–25 fields of each coverslip. Each experiment was repeated five or
more times, using separate cultures.
Statistical analysis
Statistical analysis was performed with the aid of Origin 8 (Microcal
Software Inc., Northampton, MA, USA) software. Means
expressed SEM.
Results
Effect of mtDNA mutations on
mitochondrial membrane potential
Mutations of mtDNA affecting subunits of mitochondrial com-
plexes impair the efficiency of respiration and as a result might
be expected to alter the wm. However, in the severe mutant cells
Cy3-l (Fig. 1A and B), both stem cells and differentiated cells
(neurons and glial-like cells) showed a significantly increased tetra-
methylrhodamine methylester signal (suggesting an increase in
wm). Relative to the parental cell line ES-I (taken as 100%) the
measurements of tetramethylrhodamine methylester signal inten-
sity were 144 8% for neurons (n= 112), 140 7% for glial cells
(n= 89; P50.001 for both cell types). In the stem cells there was
also an increased wm (127 8%) (n= 44 cells; P50.05) com-
pared with control cell lines, but this was significantly lower than
for differentiated cells, suggesting a different possible mechanism.
In Cy1-I and Cy2-I cells, values of tetramethylrhodamine methyl-
ester fluorescence were not significantly different from the control
ES-I cells either as differentiated cells or as undifferentiated stem
cells (Fig. 1A and B).
Mechanism of maintenance of
mitochondrial membrane potential in
cells with severe complex I deficiency
To investigate how a mutation that severely impairs complex I
activity can not only maintain wm but also be associated with
a value greater than seen in control cells, we explored the roles of
different mitochondrial mechanisms in the maintenance of mem-
brane potential. In cells with normal oxidative phosphorylation,
wm is maintained by the proton pumping activity of the respira-
tory chain. However if oxidative phosphorylation is impaired, the
F1Fo-ATP synthase (complex V) may reverse, hydrolyse ATP and
pump protons across the inner membrane, so maintaining wm
(e.g. McKenzie et al., 2007). Application of oligomycin (2 mg/ml),
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the inhibitor of the F1Fo-ATP synthase, caused a profound
decrease in wm in CY3-I neurons, with a decrease in the tetra-
methylrhodamine methylester signal by 58 5%, (n= 82; Fig. 1E).
Oligomycin either increased or did not affect wm in the other cell
lines (Fig. 1C and D). Thus, in CY3-I cells, in response to the
impaired activity of the respiratory chain, the F1Fo complex
switched to ATP consumption mode which maintained wm.
Despite carrying the same mtDNA mutation, the response of the
undifferentiated CY3-I stem cells to oligomycin was different
compared with the differentiated neuronal CY3-I cells (Fig. 1F).
In the undifferentiated cells, application of oligomycin increased
tetramethylrhodamine methylester fluorescence by 7.4 0.4%
(n= 99), in contrast to the depolarization seen in the differentiated
cells. Tetramethylrhodamine methylester fluorescence was then
significantly reduced by the subsequent addition of rotenone (by
38.2 4.1%), indicating a fall in wm. A relatively large further
decrease in signal, in response to FCCP, then suggested that com-
plex II activity must also be relatively active as a donor of electrons
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Figure 1 Characteristics of mitochondrial membrane potential (wm) in cells with mitochondrial mutations. (A–B) Neurons and astrocytes
with severe mutation in complex I (CY3-I) showed a significant increase (P50.001) inwm compared with control cells. The mitochondrial
potential in cells with a mutation in complex IV (CY2-I) showed no significant difference from control. Non-differentiated CY3-I cells also
exhibited a 26% increase (P50.05) in tetramethylrhodamine methylester (TMRM) fluorescence (i.e. an increased wm) compared with
controls. In control and CY2-I neurons (C–D), oligomycin did not affect wm; rotenone induced a partial depolarization; FCCP induced
complete depolarization. In CY3-I neurons (E), oligomycin caused a mitochondrial depolarization. In the CY3-I stem cells (F) the wm was
not maintained by reverse electron flow since oligomycin did not cause mitochondrial depolarization. P50.05; P50.001.
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in these cells. The effects of oligomycin, rotenone and FCCP in
non-differentiated cells CY2-I (n= 76), ES-I (n= 41) and CY1-I
(n= 67) were equivalent to effects in the differentiated neuron
and glial cells.
Effects of substrates on the maintenance
of mitochondrial membrane potential
It has been shown that in some models, maintenance of the wm
by ‘reverse’ ATPase activity can be corrected by giving additional
substrate, suggesting that substrate supply may be rate limiting
(Gandhi et al., 2009). Provision of additional substrate for
complex I (pyruvate, 5 mM) increased wm in CY3-I cells (by
16.1 1.1%, n= 101; P50.05), but methyl-succinate (5 mM) a
membrane-permeable analogue of succinate, the substrate for
complex II, induced a small but significant mitochondrial depolar-
ization in CY3-I neurons (by 19.1 1.1%; P50.05). Additional
mitochondrial substrates did not change the effect of oligomycin
on wm—application of the F1Fo-ATPase inhibitor increased
wm in ES-I, CY1-I and CY2-I and collapsed wm in CY3-I neu-
rons (Fig. 2A–D). Thus, the impaired maintenance of wm by the
respiratory chain in CY3-I neurons is not due to lack of substrate
supply.
Calcium homoeostasis
Mitochondria play a significant role as a spatial calcium buffering
system in maintaining neuronal calcium homoeostasis (Duchen,
2000). Physiological stimuli do not damage mitochondrial function
in healthy cells but can increase the generation of reactive oxygen
species, which when associated with mitochondrial calcium over-
load can precipitate opening of the mitochondrial permeability
transition pore. In order to investigate the influence of the mito-
chondrial mutations on calcium homeostasis we measured [Ca2+]c
and wm simultaneously using fura-2 and rhodamine 123, respec-
tively, following stimulation of cells with a variety of agonists to
raise [Ca2+]c. ATP (100 mM) was used to stimulate [Ca
2+]c signals
in astrocytes via purinoceptors, and 50 mM KCl was used to
induce depolarization of the plasma membrane and open voltage
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Figure 2 Effect of mitochondrial substrates on mechanism of maintenance of wm in cells with mitochondrial mutations. Application of
pyruvate (5 mM) or methyl succinate (5 mM) to neurons increased wm, but increased substrate provision did not prevent the oligomycin
induced mitochondrial depolarization in CY3-I neurons (C). In the presence of pyruvate, methyl-succinate induced further hyper-
polarization of mitochondria in ES-I and CY1-I neurons (A, B, D), but a small mitochondrial depolarisation in CY3-I cells.
TMRM = tetramethylrhodamine methylester.
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gated calcium channels, which are primarily expressed in neurons.
Application of 50 mM KCl to all four cell lines produced a [Ca2+]c
signal on cells of neuronal phenotype, with no significant depolar-
ization of wm (Fig. 3) as characterized before in primary neurons
(Keelan et al., 2001; Gandhi et al., 2009). Application of 100mM
ATP to glial cells in co-culture induced a [Ca2+]c signal with no
significant difference between groups of cells in amplitude or time
course (Fig. 3C–D). Raising [Ca2+]c with ATP also did not change
wm in any of the cell lines. Thus, these mitochondrial mutations
did not induce pathological changes in their mitochondrial
responses to [Ca2+]c signals under these conditions.
Production of reactive oxygen species
in mitochondria
Mitochondria are widely believed to be an important source of
reactive oxygen species in a number of neurodegenerative disease
states. The increased generation of mitochondrial reactive oxygen
species by mitochondria with an impaired respiratory chain may be
a factor in cell dysfunction in the presence of mtDNA mutations
(Fukui and Moraes, 2008). We have tried to differentiate between
reactive oxygen species generated in the cytosol and in the mito-
chondrial matrix by using hydroethidine as a cytosolic indicator
compared with signals from the mitochondrially targeted hydro-
ethidine. The rate of reactive oxygen species production was
assessed by measuring the ratio of the rate of increase in red
fluorescence (oxidized hydroethidine or ethidium) and the rate
of disappearance of the UV induced blue hydroethidine fluores-
cence (see ‘Materials and methods’ section). In order to isolate
mitochondrial from other sources of reactive oxygen species gen-
eration, inhibitors of the nicotinamide adenine dinucleotide phos-
phate oxidase (apocynin, 1 mM or 0.5 mM diphenyleneiodonium)
and xanthine oxidase (oxypurinol, 10 mM) were used (Abramov
et al., 2007). The rates of reactive oxygen species generation
both in the cytosol and in the mitochondrial matrix were not
significantly different between control (ES-I) and CY1-I cells
(Fig. 4A). The rate of reactive oxygen species production in
CY2-I neurons was significantly higher both in the mitochondrial
matrix (1.5-fold compared withwith ES-I neurons; n= 121;
P50.05) and in the cytosol (1.8-fold increase in the rate com-
pared with ES-I; n= 161; P50.05; Fig. 4A). The severe mutation
in complex I (CY3-I neurons) was also associated with a significant
increase in the rate of reactive oxygen species production in both
the matrix (1.9-fold higher than ES-I; n= 178; P50.001; Fig. 4A)
and the cytosol (3.3-fold higher than ES-I; n= 195; P50.001;
Fig. 4A).
The high rate of reactive oxygen species production in CY3-I
neurons may be a consequence of two features of the mitochon-
drial respiratory chain in these cells—a defect in complex I and a
higher wm. To explore this we used additional substrate for com-
plex I, 5 mM pyruvate, and induced a 2.2-fold increase of the rate
0.6
0.8
1.0
1.2
1.4
1.6
1.8
0 1 2 3 4 5 6
0
20
40
60
80
100
120
Fu
ra
-2
 ra
tio
ATP FCCP
R
h1
23
, %
Time (min)
CY1-I, astrocyte
0 1 2 3 4 5 6
-20
0
20
40
60
80
100
120
0.6
0.8
1.0
1.2
1.4
1.6
1.8
R
h1
23
, %
Time (min)
Fu
ra
-2
 ra
tio
CY3-I astrocyte
ATP FCCP
0.8
1.0
1.2
1.4
0 2 4 6 8 10
-20
0
20
40
60
80
100
Fu
ra
-2
 ra
tio
FCCP
50 mM KCl
CY3-I neuron
R
h1
23
, %
Time (min)
0.8
1.0
1.2
1.4
0 2 4 6 8 10
-20
0
20
40
60
80
100
Fu
ra
 -2
 ra
tio
50 mM KCl
FCCP
R
h1
23
, %
Time (min)
ES-I neuronA B
C D
Figure 3 Calcium homeostasis. Simultaneous measurements of [Ca2+]c and Wm were made from neurons (A–B) and astrocytes (C–D) in
mixed culture co-loaded with fura-2 and rhodamine 123. Traces are shown from single cells in each case. Mitochondrial mutations did not
induce pathological changes in their mitochondrial responses to [Ca2+]c signals under these conditions.
802 | Brain 2010: 133; 797–807 A. Y. Abramov et al.
of increase of the hydroethidine ratio in ES-I cells (n= 153;
P50.001) but not in CY3-I neurons (n= 114; Fig. 4B and C).
Subsequent inhibition of complex I with 5mM rotenone
induced a further increase of reactive oxygen species production
in ES-I neurons (to 3.1-fold increase relative to the basal rate)
but a decrease in CY3-I cells, (from a 3.3-fold increase in the
basal rate in ES-I neurons to 1.5-fold increase in the rate
of CY3-I cells; P50.05; Fig. 4B and C). In the CY3-I cells the
effects of substrate and rotenone suggest that reactive
oxygen species generation in CY3-I neurons is sustained by the
high wm.
In the CY2-I cells reactive oxygen species production was
increased in the presence of rotenone (to 289 24% of basal
rate for CY2-I). Pyruvate also increased reactive oxygen species
generation in CY2-I cells (163 11% of basal; n= 144) but sub-
sequent application of Wurster’s blue (TMPD; 200 mM)/ascorbate
(5 mM) inhibited reactive oxygen species production in CY2-I neu-
rons (to 106  6% of basal rate hydroethidine ratio). In the CY2-I
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Figure 4 Mitochondrial and cytosolic reactive oxygen species production in cells with mitochondrial mutations. CY3-I neurons displayed a
significantly higher basal rate of increase in mitochondrially targeted hydroethidine (Mitosox) and hydroethidine ratio, demonstrating a
higher basal production of intra-mitochondrial and extra-mitochondrial reactive oxygen species compared with control (A). Histogram
demonstrating percentage values of the rate of mitochondrially targeted hydroethidine or hydroethidine ratio compared with 100% for
control neurons. (B–E) show increase of Wm by mitochondrial substrates (pyruvate and TMPD/ascorbate) or inhibition of complex 1 with
rotenone demonstrated the dependence of reactive oxygen species production on Wm. P50.05; P50.001.
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neurons the increased reactive oxygen species production is likely
to be due to defect in complex IV.
Glutathione measurements
Cell viability in response to increased reactive oxygen species gen-
eration is dependent on the efficiency of cellular antioxidant sys-
tems. Glutathione provides one of the major antioxidant
mechanisms in the CNS. Oxidative stress—the condition in
which the rate of reactive oxygen species generation overwhelms
antioxidant defence, is typically associated with glutathione deple-
tion and leads to CNS pathology (Dringen and Hirrlinger, 2003).
MCB was used to measure glutathione status in non activated
neurons and glial cells from co-culture. Differences between the
level of glutathione concentration in neurons and astrocytes is well
established (Keelan et al., 2001; Dringen and Hirrlinger, 2003) and
was observed in these differentiated stem-cell preparations, with a
level of MCB fluorescence in all groups of neurons at about 40%
of the signal in astrocytes in the same culture (Fig. 5). Despite the
higher rate of reactive oxygen species production that we have
measured in CY2-I neurons, the mutation in complex IV was not
associated with a significant change in glutathione concentration
in the neurons or astrocytes (Fig. 5). The severe mutation in com-
plex I (CY3-I) was not only associated with increased reactive
oxygen species production in mitochondria but also with a signif-
icant reduction in glutathione concentration in both neurons and
astrocytes. The level of MCB fluorescence in CY3-I neurons was
59 4% of control (ES-I), and 62 5% for astrocytes (P50.001
for both; n= 4 experiments; Fig. 5). Thus, the severe complex I
mutation in CY3-I cells induces oxidative stress.
Cell viability
The number of functional neurons and astrocytes in a co-culture
can be estimated by counting cells that show [Ca2+]c signals
in response to physiological stimuli, KCl or ATP, which give
characteristic and distinct responses in either neurons or astrocytes
(see above). The application of glutamate (50 mM) induced robust
[Ca2+]c responses in neurons (Fig. 6A), while 100 mM ATP gave
characteristic responses in astrocytes while neurons generally did
not respond to ATP (Fig. 6B). At 7 days in vitro, the cultures
showed relative proportions of neurons (74.6 6.1%) to astro-
cytes (15.9 0.9%) (ES-I, n= 297) and 71.3 4.5% to
17.8 1.1% (CY1-I, n= 320 cells). The co-cultures of CY2-I and
CY3-I cells contained more astrocytes than control ES-I cells
(24.7 2.1% of astrocytes in CY2-I cells, n= 265; and
32.7 2.9% in CY3-I with only 34.9 2.1% neurons; n= 232
cells; Fig. 6C). With increasing time in culture, there was a pro-
gressive increase in cell death of neurons, resulting in a change in
the proportion between cell types (Fig. 6D). At 7 days in vitro the
CY2-I culture contained fewer neurons (82.6 6.9% of control)
and even less in 12 days in vitro culture (64.6% of control in
7 days in vitro). The most dramatic loss of neurons was observed
in CY3-I culture, with 59.6 4% of control cultures at 7 days
in vitro, but only 6.2 0.4% at 12 days in vitro.
Considering the very high level of reactive oxygen species gen-
eration and low level of endogenous antioxidant in CY3-I neurons
we investigated the effect of antioxidants on neuronal survival.
Incubation of the CY3-I neurons with 200 mM manganese (III)
tetrakis (4-benzoic acid)porphyrin (MnTBAP; a superoxide dismu-
tase mimic and hydrogen peroxide scavenger) significantly
reduced the number of dead neurons (measured as a % of pro-
pidium iodide positive neurons at 14 days in vitro). Thus, the pro-
portion of dead neurons in untreated CY3-I culture was
45.5 4.1%; n= 593 neurons; in cell cultures with MnTBAP pre-
treatment this fell to only 12.6 1.1%, n= 651 neurons; (P50.01,
Fig. 6F). Therefore, overproduction of reactive oxygen species in
cells with severe mutation in the complex I is an important cause
of specific neuronal death.
Discussion
We believe our approach to understanding the mechanisms
involved in neurodegeneration due to mtDNA mutations has
given us valuable insight into the neuronal consequences of
these mutations. Whilst the majority of studies were performed
on neurons and glia, limited studies were also performed on undif-
ferentiated cells including exploration of one of the fundamental
properties of mitochondria, mechanisms involved in the main-
tenance of membrane potential. For the severe complex I muta-
tion there was a significant difference between undifferentiated
cells and differentiated cells, glia and neurons. This highlights
the need to study relevant models of disease whenever possible
if we are to understand the mechanism of neurodegeneration.
Mitochondrial membrane potential
Maintenance of a membrane potential is an essential property of
mitochondria. Cells lacking in mtDNA (rho0) maintain a modest
membrane potential despite being unable to perform any oxidative
metabolism. Discharge of the mitochondrial membrane potential
has a number of consequences for the cell, including apoptosis.
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Figure 5 Glutathione in both neurons and astrocytes. MCB was
used to assess astrocyte and neuronal glutathione concentration.
Mean intensities of MCB-glutathione adduct fluorescence
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concentration was decreased compared with other cell lines in
both astrocytes and neurons.
804 | Brain 2010: 133; 797–807 A. Y. Abramov et al.
We have found that a severe mutation in complex I changes the
mechanism of maintenance of mitochondrial membrane potential
in neurons and astrocytes. In control cells and cells with complex
IV mutation, wm is maintained by the proton pumping activity of
the respiratory chain. The severe complex I mutation in neurons
and glia significantly impaired oxidative phosphorylation.
Hydrolysis of ATP by the F1Fo-ATPase (complex V) occurs under
these conditions, pumping protons across the inner membrane and
maintaining wm. Remarkably, non-differentiated embryonic stem
cells with same mutation maintain mitochondrial membrane
potential by respiratory chain activity—thus, the properties that
determine the ability to maintain wm via hydrolysis of ATP neu-
rons and glia seems to switch at the time of differentiation.
Considering the low glycolytic activity of neurons compared with
other cell types (Snyder and Wilson, 1983) enhanced consumption
of ATP in response to pathological situations such as seizures,
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Figure 6 Cell death in neurons and astrocytes. The number of functional neurons and astrocytes in a co-culture was estimated by
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common in patients with mitochondrial disease, might be poten-
tially harmful for neurons. This is of clinical relevance since epi-
lepsy is a very prominent feature of mtDNA disease, and there is
evidence that the stroke-like episodes seen in patients with the
mitochondrial encephalomyopathy, lactic acidosis and stroke-like
episodes (MELAS) syndrome are often associated with seizures
(Betts et al., 2006).
Calcium handling
An interesting observation is the normal calcium handling by the
cell lines under the experimental conditions used. Calcium ions are
central to neuronal function, transducing electrical activity into
molecular signals. In addition, altered cytosolic Ca2+ regulation
underlies entry into various cell-death pathways. Consequently,
factors that shape the Ca2+ transients are likely to assume great
importance in normal neuronal function. A key role in this regard
is played by mitochondria. The wm provides a powerful driving
force to accumulate Ca2+ from the cytosol (Vasington and
Murphy, 1962; Carafoli et al., 1964; Crompton and Heid,
1978). Agents which uncouple wm prevent mitochondria from
taking up Ca2+ and thus alter the time course of cytosolic Ca2+
transients in neurons (Werth and Thayer, 1994) and astrocytes
(Boitier et al., 1999). The preservation of wm in all cell lines
under the conditions used is the likely explanation of the normal
calcium handling in these cell lines.
Mitochondrial reactive oxygen species
It has been widely reported that inhibition of complex I and
enhanced wm are classical inducers of reactive oxygen species
generation in mitochondria (Abramov et al., 2007). The severe
complex I deficient cells demonstrated unique combination of
impaired complex I and high wm—combination of both factors
dramatically increased production of reactive oxygen species into
both the mitochondrial matrix and the cytosol. Excessive genera-
tion of free radicals induced glutathione depletion in both neurons
and astrocytes, impairing neuronal viability as glutathione deple-
tion leaves the neurons vulnerable to damage by oxidative stress.
We believe this is the mechanism by which neurons die more than
the astrocytes although features of mutations in complex I
appeared in both cell types. Astrocytes contain far higher levels
of glutathione than neurons (Dringen and Hirrlinger, 2003) and
supply amino acid precursors for neuronal glutathione synthesis.
Neurons depleted of glutathione die, probably through an inability
to withstand their intrinsic pro-oxidants (Vesce et al., 2005). In
contrast, astrocytes can sustain adequate ATP synthesis by glyco-
lytic metabolism, seem not to be as significantly damaged by loss
of mitochondrial function, and are also far more resistant to oxi-
dative stress than are the neurons.
In conclusion, we have explored the mechanism of neuronal
involvement with two different mtDNA mutations. These muta-
tions were different both in terms of the site of the genetic defect
and the severity of the biochemical defect—which probably
reflects the different biochemical phenotype of these cells. In the
cells with severe complex I deficiency there is evidence of marked
cell loss which is entirely compatible with the neuropathological
changes seen in patients with mtDNA disease. Interestingly this
cell loss was decreased in the presence of antioxidants suggesting
a role for reactive oxygen species in the cell death. This might
have important implications for the management of patients
with mtDNA disease where current treatment options are very
limited.
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